1DER
LIVE

Serial Number

99844885

Owner

1der, Inc.

Attorney

Candice Reder

Filing Date

May 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

1DER Trademark

Serial Number: 99844885

1DER is a trademark filed by 1der, Inc. on May 26, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

1der, Inc. (3 trademarks)

169 Madison Ave. Ste. 90762
New York, NY 10016

Entity Type: 03

Trademark Details

Filing Date

May 26, 2026

Registration Date

Not Registered

Goods & Services

Reagents for use in medical genetic testing; Diagnostic preparations for medical use; Diagnostic preparations for medical purposes for detecting genetic predispositions; Diagnostic preparations for use in assessment of genomic analysis for medical use; Diagnostic preparations for in vitro testing for medical use

Medical research services; Scientific research and development; Biotechnology research; Genetic testing for scientific research purposes; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of genomics; Research and development services in the field of biotechnology; Research and development in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Biotechnology research in the field of Genomics, Genetic Editing, Genetic Testing, Genetics, Stem Cell Biology; Consulting services in the field of biotechnology; Biotechnology research in the field of Genomics; Development of new technology for others in the field of Reproductive Biology, Human Reproductive Biology; Development of new technology for others in the field of Assisted Reproductive Technologies, IVF; Development of new technology for others in the field of Reproduction, Genetic Testing, Pre-implantation Genetic Testing; Scientific research relating to genetics and genetic engineering; Genotyping services for research or analysis purposes

Genetic testing for medical purposes; DNA screening for medical purposes; Structural and functional analysis of genomes for medical purposes; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Providing personalized healthcare and medical information in the nature of genomics, genetic testing and editing; Genetic counseling; Providing medical information to patients and medical professionals in the form of reports in the field of genetic testing results interpretation

Filing History

APPLICATION FILING RECEIPT MAILED
May 26, 2026 MAFR
NEW APPLICATION ENTERED
May 26, 2026 NWAP